The recent clinical trial published in JAMA Oncology revealed that a combination treatment of a PARP inhibitor and chemotherapy did not improve survival in glioblastoma patients compared to placebo.
The study explores curcumin-piperine synergizing with vitamin D to induce remission in SLE patients, diverging from traditional immunosuppressive therapies, focusing instead on enhancing natural anti-inflammatory responses.